{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:00:40Z","timestamp":1790740840342,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2023J316"],"award-info":[{"award-number":["2023J316"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014759","name":"Medical Scientific Research Foundation of Zhejiang Province, China","doi-asserted-by":"publisher","award":["2022KY1138"],"award-info":[{"award-number":["2022KY1138"]}],"id":[{"id":"10.13039\/501100014759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y202352628"],"award-info":[{"award-number":["Y202352628"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102970","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:36:37Z","timestamp":1786948597000},"page":"102970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of a three-gene prognostic signature associated with tumor immune characteristics in lung adenocarcinoma: A comprehensive analysis of multi-omics data"],"prefix":"10.1016","volume":"72","author":[{"given":"Huangkai","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102970_bib0001","first-page":"278","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.tranon.2026.102970_bib0002","unstructured":"V. Kanchustambham, S.L. Sharma Adenocarcinoma. In: StatPearls. Treasure Island (FL) relationships with ineligible companies. Discl.: Sanjeev Sharma Declar. no Relev. Financ. Relatsh. Ineligible Co..: StatPearls Publishing."},{"key":"10.1016\/j.tranon.2026.102970_bib0003","unstructured":"Copyright \u00a9 2026, StatPearls Publishing LLC.; 2026."},{"key":"10.1016\/j.tranon.2026.102970_bib0004","doi-asserted-by":"crossref","unstructured":"R.L Siegel, A.N Giaquinto, A. Jemal Cancer statistics, 2024. 2024;74(1):12\u201349.","DOI":"10.3322\/caac.21820"},{"issue":"4","key":"10.1016\/j.tranon.2026.102970_bib0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.21037\/tlcr.2018.05.14","article-title":"Lung cancer in never smokers-the East Asian experience","volume":"7","author":"Zhou","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40880-017-0187-6","article-title":"Proportion and clinical features of never-smokers with non-small cell lung cancer","volume":"36","author":"Cho","year":"2017","journal-title":"Chin. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.102970_bib0007","article-title":"Non\u2013Small cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In oncology","volume":"24","author":"Riely","year":"2026","journal-title":"J. Natl. Compr .Cancer Netw."},{"issue":"10","key":"10.1016\/j.tranon.2026.102970_bib0008","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/CAD.0000000000001118","article-title":"Role of PD-L1 assessment in advanced NSCLC: does it still matter?","volume":"32","author":"Rizzo","year":"2021","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.tranon.2026.102970_bib0009","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clin Sao Paulo Braz"},{"issue":"3","key":"10.1016\/j.tranon.2026.102970_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"7689","key":"10.1016\/j.tranon.2026.102970_bib0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2026.102970_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.21037\/tlcr-23-742","article-title":"Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review","volume":"13","author":"Mao","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"issue":"11","key":"10.1016\/j.tranon.2026.102970_bib0013","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jtho.2017.08.011","article-title":"Germline mutations in DNA repair genes in lung adenocarcinoma","volume":"12","author":"Parry","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102970_bib0014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","article-title":"The antitumorigenic roles of BRCA1\u2013BARD1 in DNA repair and replication","volume":"21","author":"Tarsounas","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-9966-32-15","article-title":"Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis","volume":"32","author":"Yang","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","article-title":"Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy","volume":"12","author":"Lim","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.tranon.2026.102970_bib0017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12859-020-03691-3","article-title":"Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma","volume":"21","author":"Zengin","year":"2020","journal-title":"BMC Bioinform."},{"issue":"9818","key":"10.1016\/j.tranon.2026.102970_bib0018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(11)61941-7","article-title":"A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies","volume":"379","author":"Kratz","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tranon.2026.102970_bib0019","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/cas.16154","article-title":"Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments","volume":"115","author":"Fukuda","year":"2024","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2026.102970_bib0021","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.7150\/ijbs.92046","article-title":"The interaction of calcium-sensing receptor with KIF11 enhances cisplatin resistance in lung adenocarcinoma via BRCA1\/cyclin B1 pathway","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0022","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41420-026-03017-x","article-title":"SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma","volume":"12","author":"Xie","year":"2026","journal-title":"Cell Death. Discov."},{"issue":"7","key":"10.1016\/j.tranon.2026.102970_bib0023","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.7150\/ijbs.71283","article-title":"TRIM44 promotes BRCA1 functions in HR repair to induce cisplatin chemoresistance in lung adenocarcinoma by deubiquitinating FLNA","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"5\u20136","key":"10.1016\/j.tranon.2026.102970_bib0024","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.tranon.2026.102970_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2026.102970_bib0026","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0028","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2026.102970_bib0029","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12881-020-01074-2","article-title":"KIAA1109 gene mutation in surviving patients with Alkuraya-Ku\u010dinskas syndrome: a review of literature","volume":"21","author":"Kumar","year":"2020","journal-title":"BMC. Med. Genet."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:44Z","timestamp":1790739284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S1936523326003062"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102970","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a three-gene prognostic signature associated with tumor immune characteristics in lung adenocarcinoma: A comprehensive analysis of multi-omics data","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102970"}}